Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis C

  Free Subscription


18.09.2017

1 Dig Dis Sci
2 Hepatology
2 J Hepatol
2 J Med Virol
2 Lancet Gastroenterol Hepatol
3 N Engl J Med
2 PLoS One
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. CHAN J, Gogela N, Zheng H, Lammert S, et al
    Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
    Dig Dis Sci. 2017 Sep 8. doi: 10.1007/s10620-017-4749.
    PubMed     Text format     Abstract available


    Hepatology

  2. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Text format     Abstract available

  3. CHEN G, Wang C, Chen J, Ji D, et al
    Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29109.
    PubMed     Text format     Abstract available


    J Hepatol

  4. FANGAZIO S, Camatta D, Minh MT, Ceriani E, et al
    Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma.
    J Hepatol. 2017 Sep 7. pii: S0168-8278(17)32280.
    PubMed     Text format    

  5. IOANNOU GN, Green PK, Berry K
    HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.
    J Hepatol. 2017 Sep 5. pii: S0168-8278(17)32273.
    PubMed     Text format     Abstract available


    J Med Virol

  6. AHMED AM, Doheim MF, Mattar OM, Sherif NA, et al
    Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta-analysis.
    J Med Virol. 2017 Sep 11. doi: 10.1002/jmv.24947.
    PubMed     Text format     Abstract available

  7. OGASAWARA N, Kobayashi M, Akuta N, Kominami Y, et al
    Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b.
    J Med Virol. 2017 Sep 14. doi: 10.1002/jmv.24950.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  8. NIEBEL M
    Living with hepatitis C.
    Lancet Gastroenterol Hepatol. 2017;2:705.
    PubMed     Text format    

  9. NIEBEL M, Singer JB, Nickbakhsh S, Gifford RJ, et al
    Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?
    Lancet Gastroenterol Hepatol. 2017;2:700-701.
    PubMed     Text format    


    N Engl J Med

  10. GOLDBERG DS, Abt PL, Reese PP
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1105.
    PubMed     Text format    

  11. MARTINS PN, Movahedi B, Bozorgzadeh A
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1104-5.
    PubMed     Text format    

  12. HALLECK F, Budde K, Duerr M, Staeck O, et al
    Transplanting HCV-Infected Kidneys into Uninfected Recipients.
    N Engl J Med. 2017;377:1103-4.
    PubMed     Text format    


    PLoS One

  13. KEATING SM, Dodge JL, Norris PJ, Heitman J, et al
    The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    PLoS One. 2017;12:e0181004.
    PubMed     Text format     Abstract available

  14. NAKAMURA M, Kanda T, Jiang X, Haga Y, et al
    Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    PLoS One. 2017;12:e0177302.
    PubMed     Text format     Abstract available


    Transplantation

  15. PRUETT TL, Clark MA, Taranto SE
    Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Transplantation. 2017;101:1670-1678.
    PubMed     Text format     Abstract available

  16. VOLK ML, Wilk AR, Wolfe C, Kaul DR, et al
    The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Transplantation. 2017;101:1666-1669.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: